Arraypatch Ltd

ArrayPatch Ltd is a clinical stage BioTech company. Our primary mission is to provide healthcare professionals with a superior treatment option, ultimately improving patient outcomes. This mission is centered around our innovative DerMap patent technology, a unique microneedle technology. The first product utilizing DerMap technology will address the fungal infection of the nail. ArrayPatch's robust product pipeline is also expanding into high-value indications including skin cancer, skin aging, migraines, and small peptide therapies for diabetics. Led by an experienced team with a strong international track record in biotech commercialization, ArrayPatch offers multiple product and exit opportunities through its scalable microneedle platform. ArrayPatch is currently in active commercial discussions with strategic partners for co-development and distribution opportunities. Additionally, we are currently seeking seed investment to accelerate our clinical development and market entry.